TSHA

Taysha Gene Therapies, Inc.

NasdaqGS · Healthcare

$6.53

-0.15% today

last filing 2026-06-01Pro sees filings in ~15 min

Price

hover · 4 moves explained

1 buy13 sells17 8-K

Analyst consensus

Strong Buy

$13.00target+99.1%vs $6.53 today

$10.00 low today target$19.00 high

13 analysts · ~12-month consensus · as of Jul 9. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 2 of last 4

Earnings per share · actual vs forecast

Q2 '25-12.5%

−$0.08

exp −$0.07

Q3 '25+2.8%

−$0.09

exp −$0.09

Q4 '25+25.3%

−$0.07

exp −$0.10

Q1 '26-14.0%

−$0.11

exp −$0.10

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-06-02	Stalfort John A III	Director	—Direct	21,335	—	—
Grant	2026-06-02	Donenberg Phillip B.	Director	—Direct	21,335	—	—
Sell	2026-02-06	Alam Kamran	CHIEF FINANCIAL OFFICER	—Direct	1,655	$4.52	$7.5K
Sell	2026-01-27	Nolan Sean P.	Chief Executive Officer	—Direct	41,312	$4.61	$190.4K
Sell	2026-01-27	Nagendran Sukumar	President and Head of R&D	—Direct	26,918	$4.61	$124.1K

Grant

Stalfort John A III

Director · 2026-06-02

—

21,335 shares

Grant

Donenberg Phillip B.

Director · 2026-06-02

—

21,335 shares

Sell

Alam Kamran

CHIEF FINANCIAL OFFICER · 2026-02-06

$7.5K

1,655 @ $4.52

Sell

Nolan Sean P.

Chief Executive Officer · 2026-01-27

$190.4K

41,312 @ $4.61

Sell

Nagendran Sukumar

President and Head of R&D · 2026-01-27

$124.1K

26,918 @ $4.61

24 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →